Virtual event

Manufacturing day
August 10, 2023
11am ET
Virtual event

The pandemic spotlight on drug manufacturing shifted the industry into a radical reality. Now that the world has moved forward — how has the new landscape affected the industry? From supply chain drain to capital expenditure hurdles, how exactly can we scale up therapies? Join Endpoints for our first manufacturing day to find out what the experts are saying about the unique environment we are facing today.

August 10, 2023
11am ET
Virtual event
0
Days
0
Hours
0
Minutes
0
Seconds
Jay Sapp

Jay Sapp

Director of Operations

Societal™ CDMO
Danielle Grosso

Danielle Grosso

Director of Project Management

Societal™ CDMO
Joe Christensen

Joe Christensen

Senior Director of Quality Control

Societal™ CDMO
Kari Abitbol

Kari Abitbol

Director, Client Success

Endpoints News
11:00 - 11:50am ET

Managing the challenges of a successful commercial tech transfer

Tech transfers are a natural, and often necessary, step in the product life cycle. Whether the need to transfer arises due to capacity issues, M&A activity, location changes, or other reasons, a tech transfer can be a daunting task. There are high stakes, a myriad of activities to complete, and an unforgiving timeline.  In this webinar, we’ll walk through key points that can bring clarity and efficiency to this critically important process. 

During this session, experts from Societal CDMO will:

  • Discuss common issues that impact commercial tech transfers
  • Provide an experienced perspective and suggestions on what to do, and what not to do, at each step of the transfer
  • Provide a path for seamless partnership
12:00 - 12:50pm ET

Scaling up on cell and gene therapies: What’s it going to take?

As more and more gene therapies reach the market, new technologies that allow manufacturers to reduce costs will be essential for their success. We’re gathering a group of biotech experts to discuss what’s needed, and how long it will take the leaders to step up.

Audrey Greenberg

Audrey Greenberg

Co-founder, Chief Business Officer

Center for Breakthrough Medicines
Lee Buckler

Lee Buckler

Senior Vice President of Advanced Therapies

Blood Centers of America
Eytan Abraham

Eytan Abraham

VP and Business Head of Emerging Modality Franchises

National Resilience
Andrew Dunn

Andrew Dunn

Biopharma Correspondent

Endpoints News

Register to watch

No cost to register, subject to confirmation. By registering for this event, you accept that you may receive direct communication from the sponsor(s). If you are experiencing problems with your registration, please contact our support team.